• At the conclusion of this activity, learners should be able to:

  • Identify risk factors associated with development immunosuppression-related lymphoproliferative disorders (LPDs)
  • Relate host cell metabolic derangements caused by latent EBV infection to potential therapeutic vulnerabilities
  • Discuss emerging strategies for manipulating the host response to viral-associated LPDs
Add to calendar: 
Session date: 
11/12/2021 - 12:00pm to 1:00pm EST

Please login or register to take this course.
Room Number: 
Zoom Meeting
Speaker Name: 
Genevieve Crane, MD, PhD